Montreal, A8CIK 12744134 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
74 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Evommune Inc | 589.0K | $10.08M | 8.1% | +589.0K | New |
| 2 | Contineum Therapeutics Inc | 800.8K | $9.15M | 7.3% | 0 | Held |
| 3 | Eli Lilly & Co | 7.3K | $7.82M | 6.3% | −2.1K | Reduced |
| 4 | Shoulder Innovations Inc |
| 492.4K |
| $7.04M |
| 5.6% |
| +62.2K |
| Added |
| 5 | Unitedhealth Group Inc | 13.6K | $4.49M | 3.6% | +50 | Added |
| 6 | Amgen Inc | 13.1K | $4.28M | 3.4% | +2.7K | Added |
| 7 | Johnson & Johnson | 20.3K | $4.20M | 3.4% | +5.0K | Added |
| 8 | Abbvie Inc | 16.8K | $3.84M | 3.1% | +2.0K | Added |
| 9 | Vertex Pharmaceuticals Inc | 8.0K | $3.63M | 2.9% | +290 | Added |
| 10 | Abbott Labs | 23.5K | $2.94M | 2.4% | +6.3K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio